Tissue Regenix Group plc

TRX.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-£1£0-£0-£1
Dep. & Amort.£1£0£1£0
Deferred Tax£0£0£0£0
Stock-Based Comp.£0£0£0-£0
Change in WC-£2£0-£3£1
Other Non-Cash£2£0£2£1
Operating Cash Flow-£0£0-£1£1
Investing Activities
PP&E Inv.-£0£0-£0-£0
Net Acquisitions£0£0£0£0
Inv. Purchases£0£0£0£0
Inv. Sales/Matur.£0£0£0£0
Other Inv. Act.-£1£0-£0-£0
Investing Cash Flow-£1£0-£0-£0
Financing Activities
Debt Repay.£1£0£3-£0
Stock Issued£0£0£0£0
Stock Repurch.£0£0£0£0
Dividends Paid£0£0£0£0
Other Fin. Act.-£1£0-£3-£0
Financing Cash Flow-£0£0£1-£1
Forex Effect-£0£0£0-£0
Net Chg. in Cash£1-£3£3£0
Supplemental Information
Beg. Cash£0£3£0£3
End Cash£1£0£3£4
Free Cash Flow-£0£0-£2£1